AKT and its substrate BAD have been shown to promote prostate cancer cell survival.
Agonists, such as carbachol, and hormones that increase intracellular calcium concentration can activate AKT leading to cancer cell survival. The LNCaP prostate cancer cells express the carbachol-sensitive M(3) -subtype of GPCR's that cause increases in intracellular calcium and activate the family of Ca(2+) /Calmodulin-dependent Protein Kinases (CaM Ks). One type of CaM Kinase, CaM Kinase Kinase (CaM KK), phosphorylates several substrates including AKT on threonine 308. AKT phosphorylation and activation enhances cell survival through phosphorylation of BAD protein and the subsequent blockade of caspase activation. Our goals were to examine the mechanism of carbachol activation of AKT and BAD in LNCaP prostate cancer cells and evaluate whether CaM KK may be mediating carbachol's activation of AKT and cell survival. Our results suggest that carbachol treatment of LNCaP cells promoted cell survival through CaM KK and its phosphorylation of AKT. The bacterial toxin anisomycin triggered caspase-3 activation in LNCaP cells that was blocked by carbachol in a CaM KK- and AKT-dependent manner. AKT and BAD phosphorylation were blocked by the selective CaM KK inhibitor, STO-609, as well as siRNA directed against CaM KK. BAD phosphorylation was also blocked by treating cells with the AKT inhibitor, AKT-X, as well as siRNA to AKT. Additionally, epinephrine promoted LNCaP cell survival through activation of AKT that was insensitive to STO-609. Taken together this data suggests a survival role for CaM KK operating through AKT and BAD in LNCaP prostate cancer cells.
Written by:
Schmitt JM, Smith S, Hart B, Fletcher L. Are you the author?
Biology Department, George Fox University, 414 N. Meridian St, Newberg, OR 97132. .
Reference: J Cell Biochem. 2011 Dec 15.
doi: 10.1002/jcb.24020. [Epub ahead of print]
PubMed Abstract
PMID: 22173970
UroToday.com Investigational Urology Section
